title: A trial of RSV immune globulin in infants and young children: the FDA's view.
authors.forename: S S
authors.initials: SS
authors.lastname: Ellenberg
authors.forename: J S
authors.initials: JS
authors.lastname: Epstein
authors.forename: J C
authors.initials: JC
authors.lastname: Fratantoni
authors.forename: D
authors.initials: D
authors.lastname: Scott
authors.forename: K C
authors.initials: KC
authors.lastname: Zoon
mesh_terms: D015982:Bias; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007231:Infant, Newborn; D008297:Male; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D018357:Respiratory Syncytial Virus Infections / Q000517:prevention & control*; D012136:Respiratory Syncytial Viruses / Q000276:immunology; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016756:Immunoglobulins, Intravenous